Background document on the CanSinoBIO Ad5-nCoV-S [‎recombinant]‎ vaccine (‎ConvideciaTM)‎ against COVID-19

Language
Published
2022

Background document to the WHO interim recommendations for use of the CanSinoBIO Ad5-nCoV-S vaccine (‎ConvideciaTM)‎ against COVID-19, issued 19 May 2022